Criteria for Screening Blood Donors: Science or Politics?-Reply

JAMA: The Journal of the American Medical Association

Volumn 278, Issue 4, 1997, Pages 289-

  Williams, Alan E ^a   Kleinman, Steven H ^b   Epstein, Jay ^c  

^a AMERICAN RED CROSS   (United States)

^b Medical Coordinating Center for the Retrovirus Epidemiology Donor Study (REDS)   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; HOMOSEXUALITY; HUMAN; INFECTION PREVENTION; INFECTION RISK; LETTER; POLITICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST;

EID: 0030802916     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03550040045028     Document Type: Letter

References (5)

1. Center for Biologics Evaluation and Research. Revised Recommendations for the Prevention of Human Immunodeficiency Virus (HIV) Transmission by Blood and Blood Products. Bethesda, Md: Food and Drug Administration; April 23, 1992.
2. Vengelen-Tyler V, ed. Technical Manual. 12th ed. Bethesda, Md; American Association of Blood Banks; 1996.
3. Petersen LR, Doll LS, White CR, et al, and the HIV Blood Donor Study Group. Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donors. Transfusion. 1993;33:552-557.
4. Busch MP, Lee LL, Satten GA, et al. Time course of detection of viral and serological markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion. 1995;35:91-97.
5. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusiontransmitted viral infections. N Engl J Med. 1996;334:1685-1690.